This inventor holds 6 USPTO granted patents, plus 4 CIPO patents and 5 EPO patents. Top assignees: Cilian Ag, Sanofi Pasteur Sa. Active years: 2006-2018.
Location History:
- Muenster, DE (2012 - 2013)
- Münster, DE (2006 - 2018)
Company Filing History:
Years Active: 2006-2018
Title: The Innovations of Marcus Hartmann
Introduction
Marcus Hartmann is a notable inventor based in Münster, Germany. He has made significant contributions to the field of biotechnology, particularly in the expression of monoclonal antibodies and viral proteins. With a total of 6 patents to his name, Hartmann's work has advanced the understanding and application of these important biological molecules.
Latest Patents
Hartmann's latest patents include innovative systems for the heterologous expression of monoclonal antibodies and viral proteins in ciliate host cells. The first patent focuses on a system that allows for the expression of monoclonal antibodies or their fragments, utilizing ciliate host cells that incorporate heterologous nucleic acid molecules. The second patent describes a similar system for the expression of viral proteins, showcasing his expertise in genetic engineering and protein production.
Career Highlights
Throughout his career, Marcus Hartmann has worked with prominent companies in the biotechnology sector, including Cilian AG and Sanofi Pasteur SA. His experience in these organizations has contributed to his development as an inventor and researcher in the field.
Collaborations
Hartmann has collaborated with esteemed colleagues such as Thomas Weide and Ulrike Bockau. These partnerships have likely enriched his research and led to further advancements in his work.
Conclusion
Marcus Hartmann's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for future innovations in monoclonal antibody and viral protein expression.